U50,488, a kappa-opioid receptor agonist, favored apoptosis in human multiple-myeloma cells expressing mu- and kappa-opioid receptors; but the antiproliferative effect was not mediated by kappa receptors [235]. The gene discussed is OPRK1; the disease is AL amyloidosis.